TGTX
$53.97-3.62%
TG Therapeutics Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%Russell 3000 0.01%US Stock Market 0.01%
TGTX financial statements
The full income statement, balance sheet, and cash-flow statement for TG Therapeutics Inc. (TGTX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 154.8M2024-09 155.7M2024-12 157.1M2025-03 158.8M2025-06 158.7M2025-09 158.8M2025-12 159.7M2026-03 153.1M2026-06 153.1M-1.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 616M+87.3% | 329M+40.8% | 234M+8290.0% | 2.79M-58.4% | 6.69M+4300.7% | |
| Cost of revenue | 101M+161.7% | 38.5M+172.4% | 14.1M+5232.5% | 265K-66.5% | 790K | |
| — | — | — | 196M-44.3% | 351M+28.4% | ||
| Research & development | 160M+69.9% | 94.3M+23.8% | 76.2M-39.2% | 125M-43.7% | 223M+34.2% | |
| Selling, general & administrative | 232M+50.4% | 154M+25.7% | 123M+28.5% | 95.5M-25.5% | 128M+18.8% | |
| Amortization of intangibles | — | — | — | 212K+0.0% | 212K-1.9% | |
| Operating income | 123M+194.1% | 41.9M+103.2% | 20.6M+109.5% | -218M+36.7% | -345M-26.0% | |
| Interest expense | 26.7M+11.2% | 24.0M+90.5% | 12.6M+23.8% | 10.2M+80.8% | 5.64M-10.9% | |
| Other non-operating income | 10.8M+40.3% | 7.69M+52.5% | 5.04M+191.8% | -5.50M-338.2% | 2.31M+139.9% | |
| Gain (loss) on equity securities | -298K+60.5% | -754K | 0.00 | 0.00 | — | |
| Pre-tax income | 107M+319.6% | 25.6M+95.9% | 13.1M+105.8% | -224M+35.7% | -348M-124497.2% | |
| Income tax | -340M-15468.1% | 2.21M+466.9% | 390K | 0.00 | 0.00 | |
| Net income | 447M+1812.4% | 23.4M+84.5% | 12.7M+105.7% | -224M+35.7% | -348M-24.6% | |
| $2.77+1746.7% | $0.15+66.7% | $0.09+105.5% | -$1.65+37.3% | -$2.63-8.7% | ||
| EPS (basic) | $3.10+1837.5% | $0.16+77.8% | $0.09+105.5% | -$1.65+37.3% | -$2.63-8.7% | |
| Weighted-avg shares (basic) | 144M-0.7% | 145M+2.4% | 142M+4.8% | 135M+2.4% | 132M+14.6% | |
| Weighted-avg shares (diluted) | 161M+0.7% | 160M+8.0% | 149M+9.7% | 135M+2.4% | 132M+14.6% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 631M+11.4% | 566M+78.1% | 318M+88.9% | 168M-49.2% | 331M-45.9% | ||
| Cash & equivalents | 79.1M-56.0% | 180M+93.6% | 92.9M-9.2% | 102M-65.8% | 299M-46.0% | |
| Short-term investments | 62.8M-52.1% | 131M+5.2% | 125M+109.8% | 59.4M+274.0% | 15.9M-69.5% | |
| Cash & short-term investments | 200M-35.9% | 311M+43.0% | 218M+24.9% | 174M-50.3% | 350M-42.1% | |
| Accounts receivable | 306M+136.6% | 129M+152.8% | 51.1M | 0.00-100.0% | 1.39M | |
| Inventory | 126M+13.7% | 110M+177.4% | 39.8M | 0.00 | — | |
| Other current assets | 57.6M+266.4% | 15.7M+65.1% | 9.52M+303.5% | 2.36M-18.2% | 2.88M+166.3% | |
| 1.06B+84.1% | 578M+75.3% | 330M+70.3% | 194M-49.0% | 380M-39.3% | ||
| Property, plant & equipment | — | — | 95.0K-69.1% | 307K-48.8% | 600K+24.7% | |
| Operating lease right-of-use | 6.28M-12.2% | 7.15M-11.2% | 8.05M-9.4% | 8.89M+3.0% | 8.63M-7.3% | |
| Goodwill | — | — | 799K+0.0% | 799K+0.0% | 799K+0.0% | |
| Long-term investments | 59.1M+7218.8% | 808K | 0.00-100.0% | 12.4M-65.1% | 35.5M | |
| Deferred tax assets | 348M | 0.00 | — | — | — | |
| Other non-current assets | 2.04M-1.4% | 2.07M-10.2% | 2.31M | — | — | |
| 154M+69.6% | 90.7M+68.8% | 53.7M+1.0% | 53.2M-18.6% | 65.4M-25.3% | ||
| Accrued liabilities | 108M+84.4% | 58.3M+51.5% | 38.5M-8.4% | 42.0M-18.1% | 51.3M+38.6% | |
| Deferred revenue | 21.2M+86.0% | 11.4M+7409.2% | 152K+0.0% | 152K | — | |
| Short-term & current debt | — | — | — | 0.00-100.0% | 975K-95.6% | |
| Current lease liability | 1.04M-9.8% | 1.16M-20.0% | 1.45M-8.5% | 1.58M+10.0% | 1.44M-13.9% | |
| Other current liabilities | 2.12M-54.1% | 4.63M+212.8% | 1.48M+26.5% | 1.17M-22.7% | 1.51M-91.7% | |
| 415M+16.9% | 355M+110.1% | 169M+25.3% | 135M-5.3% | 142M+34.0% | ||
| Long-term debt | 246M+0.5% | 244M+144.1% | 100M+40.7% | 71.1M+6.5% | 66.8M+765.6% | |
| Deferred revenue (non-current) | 8.81M-27.1% | 12.1M+100.9% | 6.02M+1872.5% | 305K-33.3% | 457K-25.1% | |
| Non-current lease liability | 7.02M-13.7% | 8.13M-11.9% | 9.23M-10.8% | 10.3M+5.0% | 9.85M-5.4% | |
| Operating lease liability (total) | 8.06M-13.2% | 9.29M-13.0% | 10.7M-10.5% | 11.9M+5.7% | 11.3M-6.6% | |
| 648M+191.4% | 222M+38.5% | 161M+174.0% | 58.6M-75.3% | 237M-54.3% | ||
| Common stock | 159K+1.9% | 156K+3.3% | 151K+3.4% | 146K+2.1% | 143K+1.4% | |
| Additional paid-in capital | 1.83B+4.0% | 1.76B+2.8% | 1.71B+8.0% | 1.59B+1.3% | 1.57B+4.4% | |
| Retained earnings | -1.08B+29.2% | -1.53B+1.5% | -1.55B-1.7% | -1.53B-14.9% | -1.33B-35.5% | |
| Treasury stock | 100M+1014.5% | 8.99M+4397.0% | 200K+0.0% | 200K-14.5% | 234K+0.0% | |
| Total equity incl. non-controlling | — | — | — | 58.6M-75.3% | 237M-54.3% | |
| Total liabilities & equity | 1.06B+84.1% | 578M+75.3% | 330M+70.3% | 194M-49.0% | 380M-39.3% | |
| Common shares issued | 159M+1.7% | 156M+3.1% | 151M+3.4% | 146M+2.2% | 143M+1.9% | |
| Common shares outstanding | 155M-0.3% | 156M+2.9% | 151M+3.4% | 146M+2.2% | 143M+1.9% | |
| Shares outstanding (cover) | 160M+1.7% | 157M+1.7% | 154M+5.5% | 146M+2.5% | 143M+1.6% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -24.8M+38.9% | -40.5M-29.0% | -31.4M+82.2% | -176M+40.4% | -296M-37.8% | ||
| Depreciation & amortization | 59.0K-13.2% | 68.0K-67.8% | 211K-30.4% | 303K+7.4% | 282K-24.6% | |
| Intangible amortization | — | — | — | 212K+0.0% | 212K-1.9% | |
| Share-based compensation | 64.7M+52.0% | 42.5M+12.1% | 37.9M-15.1% | 44.7M-27.1% | 61.3M-23.7% | |
| Deferred income taxes | -348M | 0.00 | 0.00 | — | — | |
| Change in receivables | 176M+125.9% | 78.1M+52.8% | 51.1M+3778.4% | -1.39M-200.0% | 1.39M | |
| Change in inventory | 33.5M-50.0% | 66.9M+81.0% | 36.9M | 0.00 | 0.00 | |
| 13.8M+1431.9% | -1.04M+98.0% | -50.7M-153.1% | -20.0M-5928.0% | -332K+98.6% | ||
| Capital expenditure | 214K+375.6% | 45.0K | 0.00-100.0% | 14.0K-96.5% | 401K+12.3% | |
| Free cash flow | -25.0M+38.4% | -40.6M-29.1% | -31.4M+82.2% | -176M+40.5% | -296M-37.8% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -89.7M-169.8% | 129M+76.8% | 72.7M+18694.6% | -391K-100.9% | 41.4M-93.9% | ||
| Long-term debt issued | 0.00-100.0% | 245M+879.3% | 25.0M | 0.00-100.0% | 70.0M | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 46.3M | 0.00-100.0% | 2.22M | |
| Common stock repurchased | 91.2M+941.6% | 8.76M | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -101M-215.8% | 87.0M+1029.3% | -9.36M+95.2% | -197M+22.8% | -255M-157.7% | |
| Interest paid | 24.2M+31.3% | 18.5M+110.6% | 8.77M+61.1% | 5.45M+57.1% | 3.47M-23.0% | |
| Income taxes paid | 7.88M+1475.8% | 500K | 0.00 | 0.00 | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 4.76B+0.7% | 4.73B+82.8% | 2.59B+50.4% | 1.72B-36.6% | 2.71B-62.9% | |
| P/E | 10.6×-94.7% | 202.2× | — | — | — | |
| P/S | 7.7×-46.2% | 14.4×+5.5% | 13.6×-96.0% | 342.2×-15.7% | 405.7×-99.2% | |
| P/B | 7.3×-65.4% | 21.3×+35.5% | 15.7×-8.3% | 17.1×+49.5% | 11.4×-18.7% | |
| Earnings yield | 9.4%+1799.4% | 0.49% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: TGTX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TGTX filings on SEC EDGAR → Not investment advice.